Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Advances in Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s0065-3101(24)00019-7PMID 8249712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia.

  1992cited by this paper
• Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.

  1992cited by this paper
• Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.

  1992cited by this paper
• Transfusion therapy in neonates.

  1991cited by this paper
• Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

  1991cited by this paper
• Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

  1991cited by this paper
• Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.

  1991cited by this paper
• Erythropoietin.

  1991cited by this paper
• Red cell volume and cardiac output in anaemic preterm infants.

  1990cited by this paper
• Anemia of prematurity: progress and prospects.

  1990cited by this paper
• Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

  1990cited by this paper
• Prediction of the need for transfusion during anemia of prematurity.

  1990cited by this paper
• Abnormal iron distribution in infants of diabetic mothers: spectrum and maternal antecedents.

  1990cited by this paper
• Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.

  1989cited by this paper
• Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

  1989cited by this paper
• Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.

  1989cited by this paper
• A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age.

  1989cited by this paper
• Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity".

  1988cited by this paper
• Circulating erythroid progenitors in the anemia of prematurity.

  1987cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Adequacy of iron supply for erythropoiesis: in vivo observations in humans.

  1987cited by this paper
• Blood Transfusion Effect on the Respiratory Pattern of Preterm Infants

  1987cited by this paper
• Anemia of prematurity. Current concepts in the issue of when to transfuse.

  1986cited by this paper
• Serum erythropoietin in humans at high altitude and its relation to plasma renin.

  1985cited by this paper
• Weight gain: a response to transfusion in selected preterm infants.

  1984cited by this paper
• The role of RBC transfusion in the premature infant.

  1984cited by this paper
• Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity.

  1984cited by this paper
• Iron nutrition in low-birth-weight infants.

  1984cited by this paper
• Postnatal changes in erythropoietin levels in untransfused premature infants.

  1983cited by this paper
• Anemia of prematurity.

  1981cited by this paper
• THE NUMBER OF POLYMORPHONUCLEAR LEUKOCYTES IN RELATION TO GESTATIONAL AGE IN THE NEWBORN

  1979cited by this paper
• Nonphysiological anaemia of prematurity.

  1978cited by this paper
• The anemia of prematurity. Factors governing the erythropoietin response.

  1977cited by this paper
• Purification of human erythropoietin.

  1972cited by this paper
• Leucocyte Blood Picture in Healthy Full-term and Premature Babies During Neonatal Period

  1970cited by this paper
• Control of marrow production by the level of iron supply.

  1969cited by this paper

• Chapter 77 – Erythrocyte Disorders in Infancy

  2012cites this paper
• Neonatal anemia.

  2008cites this paper
• Autologous Placental Blood Transfusion for the Therapy of Anaemic Neonates

  2002cites this paper
• Determinação dos valores hematológicos e das concentrações séricas de ferro e ferritina em sangue de cordão umbilical de recém-nascidos de termo e pré-termo no Hospital Israelita Albert Einstein de São Paulo

  2000cites this paper
• Erythropoietin in the neonate.

  1999cites this paper
• Iron deficiency in infants: three topics of current interest

  1996cites this paper
• Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions.

  1996cites this paper